FDA cleared the GPS Ankle from Blue Ortho on Oct 26, 2026 under K262567, a traditional 510(k). The device falls under product code OLO, Orthopedic Stereotaxic Instrument, regulated at 21 CFR 882.4560 as a Class 2 device. The review panel was Neurology.
FDA logged the submission as received on Jul 24, 2026. The decision came 94 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Blue Ortho in the last 12 months of the tracker.